Jim Cramer Weighs In On Under Armour, Walgreens And Teva Pharmaceutical

On CNBC's "Mad Money", Jim Cramer said that Under Armour Inc UAA had a nice move higher and it could pull back a bit. He thinks the apparel sector isn't that bad.

Cramer believes the deal between Walgreens Boots Alliance Inc WBA and Rite Aid Corporation RAD is not going to get approved, but he thinks Walgreens is going to trade higher, because the company is going to be able to issue a massive buyback. If it does get approval, Walgreens is going to cut cost and the stock should also trade higher, added Cramer.

Teva Pharmaceutical Industries Ltd (ADR) TEVA isn't a buy, believes Cramer. He explained that when the company acquired Allergan's generic business, it paid with its stock, which is about to become available for sale.